ISPOR, the professional society for health economics and outcomes research, announced the new chairs of its regional Patient Representatives Roundtables and leadership of the recently established ISPOR Patient Council.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research—announced today the publication of a series of award-winning papers offering transformative strategies to assess the value of healthcare interventions in the United States.
ISPOR, the professional society for health economics and outcomes research (HEOR), announced a new conference, ISPOR Dubai 2018 scheduled for 19-20 September 2018 in Dubai, United Arab Emirates.
ISPOR, the professional society for health economics and outcomes research, announced today the honorees for its 2018 Scientific and Leadership Awards.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that while payers recognize the value of real-world evidence, the use of such studies to inform pharmacy and therapeutic (P&T) committee decisions is limited.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a series of articles centered on affordability in healthcare. The special themed section appears in the March 2018 issue of Value in Health.
ISPOR, the professional society for health economics and outcomes research, announced the opening of a number of training programs. ISPOR’s Essential HEOR Training Program provides professional training and education in the field of health economics and outcomes research (HEOR) that covers a wide variety of course topics.
ISPOR, the professional society for health economics and outcomes research, announced plenary sessions and speakers for ISPOR 2018. The conference is scheduled for May 19-23, 2018 in Baltimore, MD, USA and will focus on the timely theme, “Real-Word Evidence, Digital Health, and the New Landscape for Health Decision Making.”
ISPOR announced today that registration is now open for a new webinar that reviews the, “Top 10 Trends in Health Economics and Outcomes Research.” This free webinar will be held on March 27, 2018 at 11:00 AM EDT and will provide an overview of the Society’s recent report.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that, on average, most women were willing to accept the risk of unnecessary follow-ups for an increased chance of detecting a cancer in screening.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a series of articles presenting and discussing the findings of the ISPOR Special Task Force on US Value Assessment Frameworks, which was co-chaired by Lou Garrison, PhD, University of Washington, and Peter Neumann, ScD, Tufts Medical Center. The special themed section, US Value Assessment Frameworks, appears in the February 2018 issue of Value in Health.
ISPOR, the professional society for health economics and outcomes research, announced today the launch of its new branding.
ISPOR, the professional society for health economics and outcomes research (HEOR), announced today the release of its “Top 10 HEOR Trends” list that identifies the most influential topics in the field of health economics and outcomes research for 2018.
ISPOR, the professional society for health economics and outcomes research, announced today that Lucinda Strycker Orsini, DPM, MPH has joined the Society’s leadership team in the role of Associate Chief Science Officer.
ISPOR, the professional society for health economics and outcomes research, announced today that it has published an updated code of ethics.
ISPOR announced the establishment of a new advisory council devoted to patient engagement. The formation of the Patient Council reflects the Society’s long-standing commitment to engagement of patient representatives in healthcare research and decision making worldwide.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a research report concluding that the quality of scientific evidence used in the health technology assessment of high-risk medical devices in countries in the European Union is low and needs improvement.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a research report suggesting that the removal of drug coverage caps may lead to improved medication persistence and help reduce the racial therapy gap in the United States.
ISPOR, the professional society for health economics and outcomes research, was honored with 6 prestigious awards at the 14th Annual Stevie Awards held on Friday evening, November 17, 2017.
ISPOR, the professional society for health economics and outcomes research, recently concluded its 20th Annual European Congress in Glasgow, Scotland, UK. The congress was held 4-8 November 2017 and facilitated discussion on the global challenge of delivering value in health care.
ISPOR, the professional society for health economics and outcomes research, held a number of sessions focused on patient engagement at its 20th Annual European Congress in Glasgow, Scotland, UK.
ISPOR, the professional society for health economics and outcomes research (HEOR), recognized the Best Podium and Poster Presentation Awardees from its 20th Annual European Congress held in Glasgow, Scotland, UK 4-8 November 2017.
ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.
ISPOR, the professional society for health economics and outcomes research,held the third plenary session, “Evolution of Value: Perspectives From Both Sides of the Atlantic” at its 20th Annual European Congress in Glasgow, Scotland, UK this morning.
ISPOR, the professional society for health economics and outcomes research, held several sessions on the topic of real-world evidence at its 20th Annual European Congress currently being held 4-8 November 2017 in Glasgow, Scotland, UK.
ISPOR, the professional society for health economics and outcomes research, held several sessions on the topic of medical devices at its 20th Annual European Congress currently being held 4-8 November 2017 in Glasgow, Scotland, UK.
ISPOR, the professional society for health economics and outcomes research, held the second plenary session, “Appraising the Appraisers: What Is the Future of Health Technology Assessment in Europe?” this morning at its 20th Annual European Congress in Glasgow, Scotland, UK.
ISPOR, the professional society for health economics and outcomes research (HEOR), held an open meeting this afternoon designed to gain member feedback on a new initiative, “ISPOR Women in HEOR/Science.”
ISPOR, the professional society for health economics and outcomes research, focused on what aspects of health technology assessment can be improved with good research practice guidance at its 20th Annual European Congress in Glasgow, Scotland, UK..
ISPOR, the professional society for health economics and outcomes research, opened its 20th Annual European Congress in Glasgow, Scotland, UK this morning with the first plenary session, “Where Is the Value in Value-Based Health Care?.”
ISPOR, the professional society for health economics and outcomes research, held several sessions on the topic of orphan drugs at its 20th Annual European Congress, currently being held 4-8 November 2017 in Glasgow, Scotland, UK.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon at its 20th Annual European Congress in Glasgow, Scotland, UK that explored the question, “what is ‘unmet medical need?’”
ISPOR, the professional society for health economics and outcomes research, held an important discussion on the challenges inherent in assessing new antibiotics in a world facing the growing threat of antibiotic resistance.
ISPOR released the final program and speakers for its upcoming 20th Annual European Congress scheduled for 4-8 November 2017 in Glasgow, Scotland, UK.
ISPOR announced a new initiative that is focused on the competencies necessary for professionals working in the field of health economics and outcomes research—the ISPOR Health Economics and Outcomes Research Competencies Framework™.
ISPOR announced plenary sessions and speakers for its 20th Annual European Congress that will be held 4-8 November 2017 in Glasgow, Scotland, UK. The congress will center on the theme, “The Evolution of Value in Health Care.”
ISPOR held its second plenary session, The Voice of the Patient, at its 6th Latin America Conference today focusing on how countries in the region can better incorporate the patient voice in the health care decision-making process.
ISPOR held the first plenary session of its 6th Latin America Conference today exploring the challenges and opportunities inherent in the move many of the region’s countries are taking toward universal health care coverage.
ISPOR published of a special collection of papers from both ISPOR and ISPE as part of their Joint "Special Task Force on Real-World Evidence in Health Care Decision Making" in the September 2017 issue of Value in Health. These guidance documents provide new recommendations for conducting studies using real-world data.
ISPOR, the leading professional society for health economics and outcomes research, announced confirmation of the scientific sessions for its upcoming 6th Latin America Conference scheduled for 15-17 September 2017 in São Paulo, Brazil.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for Pharmacoepidemiology (ISPE) announced their plans for a 1-day conference focused on real-world evidence. The “ISPOR/ISPE Summit on Real-World Evidence in Health Care Decision Making” is scheduled for October 20, 2017 in Washington, DC, USA.
Two ISPOR leaders have been named to the renowned list of 2017 PharmaVOICE 100 honorees. Immediate Past-President Lou Garrison, PhD and Chief Executive Officer and Executive Director Nancy S. Berg have been named 2017 PharmaVOICE 100 honorees by PharmaVOICE magazine.
Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research examining the relationship between the efficacy of randomized controlled trials and real-world effectiveness for oncology treatments.
Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research that sheds light on health care stakeholders’ perceptions of what qualifies as “real-world data.”
ISPOR announced today the publication of a new Task Force Report, "Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force," in the July/August 2017 issue of Value in Health.
ISPOR announced that the impact factor for Value in Health, the Society’s official journal, has increased to 4.235 based on new data released by Clarivate Analytics’ Journal Citation Reports.
ISPOR announced the plenary sessions and speakers for its 6th Latin America Conference scheduled for 15-17 September 2017 in São Paulo, Brazil.
ISPOR announced the election of the Society’s 2017-2018 Board of Directors. The new Board will assume office on July 1, 2017.
ISPOR recently concluded its 22nd Annual International Meeting in Boston, MA, USA. The conference attracted 4,195 delegates representing 76 countries—the largest attendance to date for the Society’s Annual International Meeting.
ISPOR hosted its third and final plenary session this morning focusing on the usefulness of big data in health care policy decisions at ISPOR’s 22nd Annual International Meeting in Boston, MA, USA.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right